| 000 | 01404nam a22004215i 4500 | ||
|---|---|---|---|
| 001 | 978-1-4614-4875-4 | ||
| 003 | DE-He213 | ||
| 005 | 20140220082817.0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 120817s2013 xxu| s |||| 0|eng d | ||
| 020 |
_a9781461448754 _9978-1-4614-4875-4 |
||
| 024 | 7 |
_a10.1007/978-1-4614-4875-4 _2doi |
|
| 050 | 4 | _aRS380 | |
| 050 | 4 | _aRS190-210 | |
| 072 | 7 |
_aTDCW _2bicssc |
|
| 072 | 7 |
_aMED072000 _2bisacsh |
|
| 082 | 0 | 4 |
_a615.19 _223 |
| 100 | 1 | _aDe, Arnab. | |
| 245 | 1 | 0 |
_aApplication of Peptide-Based Prodrug Chemistry in Drug Development _h[electronic resource] / _cby Arnab De. |
| 260 |
_aNew York, NY : _bSpringer New York : _bImprint: Springer, _c2013. |
||
| 300 | _bdigital. | ||
| 490 | 0 |
_aSpringerBriefs in Pharmaceutical Science & Drug Development, _x1864-8118 |
|
| 650 | 0 | _aMedicine. | |
| 650 | 0 | _aToxicology. | |
| 650 | 0 | _aPharmaceutical technology. | |
| 650 | 0 | _aDiabetes. | |
| 650 | 1 | 4 | _aBiomedicine. |
| 650 | 2 | 4 | _aPharmaceutical Sciences/Technology. |
| 650 | 2 | 4 | _aPharmacology/Toxicology. |
| 650 | 2 | 4 | _aDiabetes. |
| 710 | 2 | _aSpringerLink (Online service) | |
| 773 | 0 | _tSpringer eBooks | |
| 776 | 0 | 8 |
_iPrinted edition: _z9781461448747 |
| 830 | 0 |
_aSpringerBriefs in Pharmaceutical Science & Drug Development, _x1864-8118 |
|
| 856 | 4 | 0 | _uhttp://dx.doi.org/10.1007/978-1-4614-4875-4 |
| 912 | _aZDB-2-SME | ||
| 999 |
_c95246 _d95246 |
||